Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL

Abstract

BackgroundThe majority of studies on quality of oral anticoagulation (OAC) therapy with vitamin K-antagonists are performed with short-acting warfarin. Data on long-acting phenprocoumon, which is frequently used in Europe for OAC therapy and is considered to enable more stable therapy adjustment, are scarce. In this study, we aimed to assess quality of OAC therapy with phenprocoumon in regular medical care and to evaluate its potential for optimization in a telemedicine-based coagulation service.MethodsIn the prospective observational cohort study program thrombEVAL we investigated 2,011 patients from regular medical care in a multi-center cohort study and 760 patients from a telemedicine-based coagulation service in a single-center cohort study. Data were obtained from self-reported data, computer-assisted personal interviews, and laboratory measurements according to standard operating procedures with detailed quality control. Time in therapeutic range (TTR) was calculated by linear interpolation method to assess quality of OAC therapy. Study monitoring was carried out by an independent institution.ResultsOverall, 15,377 treatment years and 48,955 international normalized ratio (INR) measurements were analyzed. Quality of anticoagulation, as measured by median TTR, was 66.3% (inte rquartile range (IQR) 47.8/81.9) in regular medical care and 75.5% (IQR 64.2/84.4) in the coagulation service (P <0.001). Stable anticoagulation control within therapeutic range was achieved in 63.8% of patients in regular medical care with TTR at 72.1% (IQR 58.3/84.7) as compared to 96.4% of patients in the coagulation service with TTR at 76.2% [(IQR 65.6/84.7); P = 0.001)]. Prospective follow-up of coagulation service patients with pretreatment in regular medical care showed an improvement of the TTR from 66.2% (IQR 49.0/83.6) to 74.5% (IQR 62.9/84.2; P <0.0001) in the coagulation service. Treatment in the coagulation service contributed to an optimization of the profile of time outside therapeutic range, a 2.2-fold increase of stabile INR adjustment and a significant decrease in TTR variability by 36% (P <0.001).ConclusionsQuality of anticoagulation with phenprocoumon was comparably high in this real-world sample of regular medical care. Treatment in a telemedicine-based coagulation service substantially improved quality of OAC therapy with regard to TTR level, frequency of stable anticoagulation control, and TTR variability.Trial registrationClinicalTrials.gov, unique identifier NCT01809015, March 8, 2013.Electronic supplementary materialThe online version of this article (doi:10.1186/s12916-015-0268-9) contains supplementary material, which is available to authorized users.

e‐Health‐based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study

“…In a subgroup analysis of individuals with pretreatment in regular medical care, TTR increased from 66.2% (95% CI, 49.0%/83.6%) during treatment in regular medical care to 74.5% (95% CI, 62.9%/84.2%) in the coagulation service (‘before–after study’). This observation was accompanied by a significant decrease of variability of TTR and a 2.2‐fold higher frequency of stable anticoagulation control in the coagulation service . The importance of these findings is also reflected by the Randomized Evaluation of Long‐term Anticoagulation Therapy (RE‐LY) trial comparing dabigatran and warfarin in patients with atrial fibrillation: in this study, the difference in clinical outcome of patients receiving VKAs or novel oral anticoagulants (NOACs) was dependent on the quality of INR control .…”

Mobile health solutions for the aging population: A systematic narrative analysis

“…30,33,35,36,38,41,45,47,49,56,57 mHealth enables selfmonitoring, self-management, self-medication, overcomes issues of anxiety that can be experienced in crowded environments such as clinics, hospitals or even malls, and it enables patients to live alone and increase their health literacy. Themes of understanding and visibility were mentioned in 8/60 occurrences (13%).…”

“…23,30,31,33,35,36,38,41,45,47,[49][50][51][52][53][54][55][56][57][58][59] Table 1 illustrates and rank orders the themes from analysis of the facilitators of adoption based on frequency of their occurrence in the literature.…”

Potential Causes and Implications of Low Target Therapeutic Ratio in Warfarin-Treated Patients for Thrombosis Prophylaxis: A Single-Center Experience

“…Such order sets along with patient-related variables (ie, HAS-BLED and CHA 2 DS 2 -VASc scores) can be integrated into a computerized order entry system. [24][25][26][27][28][29][30]…”